3
Shared Docs
3
Same-Page
3 / 3
Mentions
Maggie Monast; and ClearPath Executive Director Rich Powell; 1:00 PM Cabinet Officers: • Treasury Se
ustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v
Maggie Monast; and ClearPath Executive Director Rich Powell; 1:00 PM Cabinet Officers: EFTA00148937
nsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v
Maggie Monast; and ClearPath Executive Director Rich Powell; 1:00 PM Cabinet Officers: • Treasury Se
ustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human Rights Commission v
Entities connected to both Marc Rich and Robert Bradway

Jeffrey Epstein
PERSONLeon Black
PERSON
Prince Andrew
PERSON
Alan Dershowitz
PERSON
Condoleezza Rice
PERSON
George Mitchell
PERSON
Donald Trump
PERSON
Joe Biden
PERSON
Alfredo Rodriguez
PERSON
United States
LOCATION
Bill Clinton
PERSON
Eric Trump
PERSON
Boris Nikolic
PERSONPeggy Siegal
PERSON
Julie K. Brown
PERSON
Michael Cohen
PERSON
John Brennan
PERSON
Stephen Hawking
PERSON
Wilbur Ross
PERSON
Barack Obama
PERSON